J2KBIO Co., Ltd.
J2KBIO Co., Ltd., a bio venture company, offers active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.
J2KBIO Co., Ltd. (420570) - Total Liabilities
Latest total liabilities as of September 2025: ₩4.59 Billion KRW
Based on the latest financial reports, J2KBIO Co., Ltd. (420570) has total liabilities worth ₩4.59 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
J2KBIO Co., Ltd. - Total Liabilities Trend (2021–2024)
This chart illustrates how J2KBIO Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
J2KBIO Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of J2KBIO Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nanoco Group plc
PINK:NNOCF
|
USA | $53.76 Million |
|
Clientron Corp.
TWO:8119
|
Taiwan | NT$516.82 Million |
|
SCI Engineered Materials Inc
OTCQB:SCIA
|
USA | $3.09 Million |
|
Emyria Ltd
AU:EMD
|
Australia | AU$1.31 Million |
|
Summit
TA:SMT
|
Israel | ILA5.48 Billion |
|
Y-Optics Manufacture Co. Ltd
KQ:066430
|
Korea | ₩7.90 Billion |
|
PIMS Inc.
KQ:347770
|
Korea | ₩35.11 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down J2KBIO Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how J2KBIO Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for J2KBIO Co., Ltd. (2021–2024)
The table below shows the annual total liabilities of J2KBIO Co., Ltd. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩4.62 Billion | +9.99% |
| 2023-12-31 | ₩4.20 Billion | -37.88% |
| 2022-12-31 | ₩6.77 Billion | -6.25% |
| 2021-12-31 | ₩7.22 Billion | -- |